With Covid Fading, Clorox’s Stock Is Roughly Back Where It Began
(Bloomberg) -- As Covid-19 swept across the U.S. last year, Clorox Co.'s wipes and cleaning products disappeared from store shelves due to surging demand for disinfectants, sending the company's stock to its highest level ever.
This year, however, has been a different story. With Covid receding, Clorox shares are down around 19%, wiping out their pandemic-era gains. The company, which is due to report earnings Monday after the market closes, is trading around where it did at the beginning of March 2020, before it rocketed nearly 50% to an August 2020 peak. Analysts, whose price targets averaged above $220 at the height of the rally, have brought that down to $161 on average.
“I would say the overall sentiment is still cautious on Clorox, given the tough comparisons ahead and the cost pressures,” JPMorgan analyst Andrea Teixeira said in an interview.
Teixeira, who boosted her rating from an underweight to overweight in March 2020, pulled it back to be neutral in October 2020. “Most of the good news was priced in,” she said.
Clorox shares are little changed as of 1:52 p.m. in New York on Monday.
Read more: Clorox to Report Results; Shares Down 19.0% YTD: Preview
The company's earnings report will offer a glimpse of how rising cost pressures on things like low-density resin and expected revenue declines could be pressuring margins, according to Bloomberg Intelligence. The market will be trying to determine whether the worst of the cost increases have already been felt, senior consumer analyst Mike Dennis said in an interview.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.